Conducted at the request of the Department of Health and Human Services’ Office of Infectious Disease and HIV/AIDS Policy (OIDP), this report identifies the barriers to greater integration of OUD and infectious disease services and offers strategies to overcome those barriers.
On September 10, 2019, the Centers for Disease Control and Prevention (CDC) released their 2017 Viral Hepatitis Surveillance Report. The report comes after the World Health Assembly in 2016, where the United States agreed to adopt the first ever Global Hepatitis Strategy, with the goal of eliminating viral hepatitis by 2030. The 65-page Read more…
The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence review on screening for hepatitis C virus infection in adolescents and adults. The Draft Recommendation Statement and Draft Evidence Review are available for review and public comment until September 23, 2019 here!
Gina M. Simoncini, MD, MPH; David E. Koren, PharmD Published in the Journal of the American Board of Family Medicine This special communication reviews HCV treatment resources, discusses data demonstrating similar cure rates between PCPs and specialists, and argues that capacity-building among PCPs will be necessary to control the HCV Read more…
A study published in the Journal of Hepatology looked at a DAA regimen in patients with a history of poor adherence or treatment interruption, as well as in patients with HIV/HCV coinfection. The RESOLVE study aimed to assess the safety and efficacy of this combination in patients with HCV infection Read more…
Want to contribute to national health research? The All of Us Research Program is an exciting initiative from the National Institutes of Health. The goal is simple: to speed up health research and medical breakthroughs by building one of the largest health databases of its kind. To do this, the PA research program Read more…
HIV-positive men living in New York City who clear hepatitis C virus (HCV), whether spontaneously or through treatment, are reinfected with hep C at a high rate that is comparable to that of their European counterparts. Previous studies conducted among HIV-positive MSM in Europe have found that those treated for Read more…
Background Hepatitis C virus (HCV) testing in persons born from 1945 to 1965 has had limited adoption despite guidelines, particularly among racial/ethnic minorities and socioeconomically disadvantaged patients, who have a higher prevalence of disease burden. We examined the effectiveness of a multifaceted intervention to improve HCV screening in a large Read more…
The first prospective study of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection in patients with any type of cancer has not only demonstrated that the treatment is safe and efficacious in this population, but that attaining sustained virologic response (SVR) can confer eligibility to participate in chemotherapeutic trials. Read more…
A team of Penn surgeons has successfully transplanted hepatitis C-infected hearts into uninfected patients and then cured them of the virus, according to a new study published by the American Journal of Transplantation. The clinical trial — which tested the safety of hepatitis C-infected donor organs — included 10 transplant Read more…